SOAT1 and rheumatoid arthritis: Similarly, pro-inflammatory and anti-inflammatory cytokines central to rheumatoid arthritis (RA) can be produced additionally through the JAK-STAT pathway, explaining the clinical efficacy of JAK inhibition in RA management [5].